Report of Foreign Issuer (6-k)

Date : 04/20/2017 @ 5:02PM
Source : Edgar (US Regulatory)
Stock : Aurinia Pharmaceuticals (MM) (AUPH)
Quote : 6.1  -0.01 (-0.16%) @ 4:11PM

Report of Foreign Issuer (6-k)


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 6-K


  REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934

Dated April 20, 2017

Commission File Number 001-36421


AURINIA PHARMACEUTICALS INC.
(Exact name of Registrant as specified in its charter)


N/A
(Translation of Registrant’s Name)

#1203-4464 Markham Street
Victoria, British Columbia
V8Z7X8
(250) 708-4272
(Address and telephone number of registrant’s principal executive offices)


Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F       Form 40-F 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes        No  

This Form 6-K is hereby filed and incorporated by reference into the Registrant’s Registration Statement on Form F-10 (File No. 333-206994).



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated:

April 20, 2017.

 

Aurinia Pharmaceuticals Inc.

 

 

 

By:

/s/ Celia Economides

 

Name:

Celia Economides

 

 

Title:

Head of IR & Communications

2

EXHIBIT INDEX

Exhibit

 

Description of Exhibit

 
99.1

News Release – AURINIA RELEASES ADDITIONAL 48-WEEK DATA FROM THE AURA-LV STUDY DURING LATE-BREAKING SESSION AT THE NATIONAL KIDNEY FOUNDATION 2017 SPRING CLINICAL MEETINGS

Exhibit 99.1 included with this report on Form 6-K is hereby incorporated by reference as an exhibit to the Registrant’s Registration Statement on Form F-10 (File No. 333-206994), as amended or supplemented.

3

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)
Historical Stock Chart

1 Year : From Aug 2016 to Aug 2017

Click Here for more Aurinia Pharmaceuticals Inc Charts.

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)
Intraday Stock Chart

Today : Monday 21 August 2017

Click Here for more Aurinia Pharmaceuticals Inc Charts.

Latest AUPH Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.